Back

Comparison of cardiovascular disease risk assessment tools in primary prevention patients with raised lipoprotein(a)

30 August 2024 (10:00 - 10:50)
Organised by: Logo
Congress Presentation Part of: Lipids as risk factors for cardiovascular disease Scores ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Henry Charles Carlton

Western Sussex Hospitals NHS Foundation Trust, Chichester (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Physician disagreement with treatment guidelines as a critical barrier to achieving low-density lipoprotein cholesterol targets in very high-risk patients: an implementation science study
Associate Professor K. Cho (Gwangju, KR)
Abstract Slides Video
Presentation thumbnail
Lipoprotein(a) and atherosclerotic cardiovascular disease in a Brazilian tertiary hospital population
Doctor V. Zorzanelli Rocha (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Impact of glucose metabolism status on the relationship between remnant cholesterol and ischemic risk after percutaneous coronary intervention: a large-scale long-term cohort study from real-world
Doctor K. Yan (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Association between lipoprotein particle concentration and size and progression of coronary plaque: the MACS Longitudinal Coronary CT angiography study
Doctor R. Quispe (Baltimore, US)
Abstract Slides Video
Presentation thumbnail
The association of inflammation, triglycerides and lipoprotein(a) with cardiovascular events in the UK Biobank
Doctor B. Tucker (Sydney, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids as risk factors for cardiovascular disease

The Event

Event poster

ESC Congress 2024

30 August 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Lipoprotein(a) measurements identify patients with elevated likelihood of obstructive coronary artery disease despite very low or low clinical likelihood
thumbnail
Congress Presentation
Contribution of Lipoprotein(a) to polygenic risk of coronary artery disease: A prospective UK Biobank analysis
thumbnail
Congress Session
Late-Breaking Clinical Science: lipids and cardiovascular risk

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources